Retinal laser diode photocoagulation was applied to 141 (80.6%) and intravitreal anti-VEGF (bevacizumab) injection was applied to 34 (19.4%) of 175 infants with ROP who needed treatment. Here, VEGFA is linked to retinopathy of prematurity.